Cost-per-remitter for esketamine nasal spray versus quetiapine for treatment-resistant depression

Cost-per-remitter for esketamine nasal spray versus quetiapine for treatment-resistant depression

Aim: Estimate the cost-per-remitter with esketamine nasal spray plus an oral antidepressant (ESK NS + OAD) versus quetiapine extended release plus an oral antidepressant (QTP XR + OAD) among adults with treatment-resistant depression (TRD). Materials & methods: An Excel-based model was develop...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristin Clemens, Amanda Teeple, Benoit Rive, Noam Kirson, Urvi Desai, Jason Doran, Diab Eid, Alice Qu, Hannah Bowrey, Kruti Joshi
Format: Article
Language:English
Published: Becaris Publishing Limited 2025-06-01
Series:Journal of Comparative Effectiveness Research
Subjects:
cost-benefit
cost-per-remitter
cost efficiency
cost offset
economic model
esketamine
quetiapine
treatment-resistant depression
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items